• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉通路装置废弃血液的回输。

Reinfusion of discard blood from venous access devices.

作者信息

Cosca P A, Smith S, Chatfield S, Meleason A, Muir C A, Nerantzis S, Petrofsky M, Williams S

机构信息

National Institutes of Health, National Cancer Institute in Bethesda, MD, USA.

出版信息

Oncol Nurs Forum. 1998 Jul;25(6):1073-6.

PMID:9679265
Abstract

PURPOSE/OBJECTIVES: To determine if clots are present in the initial 10 ml of blood routinely discarded from venous access devices (VADs) prior to blood sampling, and to determine if clots form in the discard blood specimen during the five minutes required to complete blood specimen sampling.

DESIGN

A pretest/post-test design.

SETTING

A large, mid-Atlantic research institution.

SAMPLE

A convenience sample of 50 adult patients with cancer (27 males and 23 females) with a median age of 60. A large sampling size variation existed among the different VADs.

METHOD

Two 5 ml discard specimens were drawn into separate syringes. Syringe #1 was filtered immediately, and syringe #2 was filtered after a five-minute dwell time. Both samples were filtered through a 40 micron filter.

MAIN RESEARCH VARIABLE

The presence or absence of clots.

FINDINGS

Fifty percent (n = 25) of the VADs had clots present on the filter from syringe #1. The clots varied in length, width, depth, and diameter, which precluded a consistent measurement. The investigators were able to measure either the diameter or length, depending on the shape of the clots. The majority of the clots (n = 17) appeared to be shaped like the lumen of a catheter and varied from 0.1 cm to 1.2 cm in length. Six clots were round and varied in diameter from 1.6 mm to 2.8 mm. Only 4% (n = 2) of the VADs had clots in syringe #2, but those clots were much larger, measuring 8.3 mm and 18.4 mm.

CONCLUSIONS

The study addresses concerns of the investigators regarding the clinical practice of reinfusing discard blood obtained from VADs. Whether the clots present in the catheter and their reinfusion represent a significant risk to patient outcome is unclear.

IMPLICATIONS FOR NURSING PRACTICE

Until further research is conducted and the degree of risk can be better defined, methods of drawing blood that require reinfusion of discard blood from VADs are not recommended.

摘要

目的/目标:确定在采血前从静脉通路装置(VAD)常规丢弃的最初10毫升血液中是否存在凝块,并确定在完成血标本采集所需的五分钟内,丢弃的血标本中是否会形成凝块。

设计

前测/后测设计。

地点

大西洋中部的一家大型研究机构。

样本

50例成年癌症患者(27例男性和23例女性)的便利样本,中位年龄为60岁。不同的VAD之间存在很大的样本量差异。

方法

将两份5毫升的丢弃标本分别抽入单独的注射器中。注射器1立即过滤,注射器2在静置五分钟后过滤。两份样本均通过40微米的过滤器过滤。

主要研究变量

凝块的有无。

结果

50%(n = 25)的VAD在注射器1的过滤器上有凝块。凝块在长度、宽度、深度和直径上各不相同,无法进行一致的测量。研究人员能够根据凝块的形状测量其直径或长度。大多数凝块(n = 17)看起来像导管腔的形状,长度从0.1厘米到1.2厘米不等。六个凝块是圆形的,直径从1.6毫米到2.8毫米不等。只有4%(n = 2)的VAD在注射器2中有凝块,但这些凝块要大得多,尺寸为8.3毫米和18.4毫米。

结论

该研究解决了研究人员对回输从VAD获得的丢弃血液的临床实践的担忧。导管中存在的凝块及其回输是否对患者预后构成重大风险尚不清楚。

对护理实践的启示

在进行进一步研究并能更好地确定风险程度之前,不建议采用需要回输VAD丢弃血液的采血方法。

相似文献

1
Reinfusion of discard blood from venous access devices.静脉通路装置废弃血液的回输。
Oncol Nurs Forum. 1998 Jul;25(6):1073-6.
2
Discard volumes necessary for clinically useful coagulation studies from heparinized Hickman catheters.从肝素化的希克曼导管中丢弃临床有用的凝血研究所需的血量。
Oncol Nurs Forum. 1996 May;23(4):671-5.
3
Methods of drawing blood samples through central venous catheters in pediatric patients undergoing bone marrow transplant: results of a national survey.
Oncol Nurs Forum. 1994 Jun;21(5):879-84.
4
A study to determine the minimum volume of blood necessary to be discarded from a central venous catheter before a valid sample is obtained in children with cancer.一项确定癌症患儿在获取有效样本前需从中心静脉导管丢弃的最低血量的研究。
Pediatr Blood Cancer. 2007 Jun 15;48(7):687-95. doi: 10.1002/pbc.20873.
5
Accuracy of drawing coagulation samples from heparinized arterial lines.从肝素化动脉导管采集凝血样本的准确性。
Am J Crit Care. 1993 Jan;2(1):88-95.
6
Comparison of PT and aPTT values drawn by venipuncture and arterial line using three discard volumes.使用三种弃血体积比较经静脉穿刺和动脉留置导管采集的PT和活化部分凝血活酶时间(aPTT)值。
Am J Crit Care. 1992 Nov;1(3):94-101.
7
Nurse and patient satisfaction with three types of venous access devices.护士和患者对三种静脉通路装置的满意度。
Oncol Nurs Forum. 1997 Jan-Feb;24(1 Suppl):34-40.
8
Hickman catheter clots: a common occurrence despite daily heparin flushing.
Cancer Treat Rep. 1987 Jun;71(6):651-3.
9
Effect of drawing a discard tube on PT and APTT results in healthy adults.抽取废弃管对健康成年人凝血酶原时间(PT)和活化部分凝血活酶时间(APTT)结果的影响。
Clin Lab Sci. 2003 Winter;16(1):16-9.
10
Quantifying the minimum discard sample required for accurate arterial blood gases.量化准确测定动脉血气所需的最小弃血样本量。
Nurs Res. 1989 Sep-Oct;38(5):276-9.

引用本文的文献

1
Clot formation risk in the clearing fluid after arterial catheter blood sampling: coagulation factors consumption over time - a prospective pilot study.动脉导管采血后清除液中的凝血形成风险:凝血因子随时间的消耗——一项前瞻性初步研究。
J Clin Monit Comput. 2025 Jun;39(3):607-612. doi: 10.1007/s10877-024-01252-0. Epub 2024 Dec 12.
2
Optimal volume for the draw-and-return methods to enhance activated partial thromboplastin time ratio accuracy in hemodialysis patients with central venous catheters.在使用中心静脉导管的血液透析患者中,采用回抽法提高活化部分凝血活酶时间比值准确性的最佳采血量。
Heliyon. 2024 Mar 24;10(7):e28651. doi: 10.1016/j.heliyon.2024.e28651. eCollection 2024 Apr 15.
3
Accuracy of laboratory tests drawn by pull-push method from central venous catheterization after routine flushing with 10 ml normal saline in patients with sepsis at the emergency department.
急诊科脓毒症患者经10 ml生理盐水常规冲管后,采用推拉法从中心静脉导管采集的实验室检查结果的准确性。
Heliyon. 2021 Jun 23;7(6):e07355. doi: 10.1016/j.heliyon.2021.e07355. eCollection 2021 Jun.
4
A Standard Push-Pull Protocol for Waste-Free Sampling in the Pediatric Intensive Care Unit.儿科重症监护病房无废物采样的标准推挽协议。
J Infus Nurs. 2018 May/Jun;41(3):189-197. doi: 10.1097/NAN.0000000000000279.